Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study.

Ernst FR, Sandulli W, Elmor R, Welstead J, Sterman AB, Lavan M.

Drugs R D. 2017 Mar;17(1):103-115. doi: 10.1007/s40268-016-0150-z.

2.

Drug disposition before and after gastric bypass: fenofibrate and posaconazole.

Gesquiere I, Hens B, Van der Schueren B, Mols R, de Hoon J, Lannoo M, Matthys C, Foulon V, Augustijns P.

Br J Clin Pharmacol. 2016 Nov;82(5):1325-1332. doi: 10.1111/bcp.13054.

PMID:
27367040
3.

Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.

Boerlage TC, Westerink F, Poland DC, Huibregtse IL, Acherman YI, Gerdes VE.

Obes Surg. 2016 Dec;26(12):2974-2980.

4.
5.

Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project.

McMillan M, Rotenberg KS, Vora K, Sterman AB, Thevathasan L, Ryan MF, Mehra M, Sandulli W.

Drugs R D. 2016 Mar;16(1):53-68. doi: 10.1007/s40268-015-0116-6.

6.

A Review of the Toxicologic Implications of Obesity.

Zuckerman M, Greller HA, Babu KM.

J Med Toxicol. 2015 Sep;11(3):342-54. doi: 10.1007/s13181-015-0488-6. Review.

7.

Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.

Gesquiere I, Darwich AS, Van der Schueren B, de Hoon J, Lannoo M, Matthys C, Rostami A, Foulon V, Augustijns P.

Br J Clin Pharmacol. 2015 Nov;80(5):1021-30. doi: 10.1111/bcp.12666.

8.

Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.

Chan LN, Lin YS, Tay-Sontheimer JC, Trawick D, Oelschlager BK, Flum DR, Patton KK, Shen DD, Horn JR.

Pharmacotherapy. 2015 Apr;35(4):361-9. doi: 10.1002/phar.1560.

9.

Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery.

Pirola I, Formenti AM, Gandossi E, Mittempergher F, Casella C, Agosti B, Cappelli C.

Obes Surg. 2013 Sep;23(9):1493-6. doi: 10.1007/s11695-013-1015-y.

10.

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S; American Association of Clinical Endocrinologists.; Obesity Society.; American Society for Metabolic & Bariatric Surgery..

Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27. doi: 10.1002/oby.20461.

11.

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S; American Association of Clinical Endocrinologists.; Obesity Society.; American Society for Metabolic & Bariatric Surgery..

Endocr Pract. 2013 Mar-Apr;19(2):337-72. doi: 10.4158/EP12437.GL.

12.

Possible risk factors for increased suicide following bariatric surgery.

Mitchell JE, Crosby R, de Zwaan M, Engel S, Roerig J, Steffen K, Gordon KH, Karr T, Lavender J, Wonderlich S.

Obesity (Silver Spring). 2013 Apr;21(4):665-72. doi: 10.1002/oby.20066. Review.

13.

Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin.

Jakobsen GS, Skottheim IB, Sandbu R, Christensen H, Røislien J, Asberg A, Hjelmesæth J.

Surg Endosc. 2013 Jun;27(6):2094-101. doi: 10.1007/s00464-012-2716-3.

14.

Drug interactions: a primer for the gastroenterologist.

Doligalski CT, Tong Logan A, Silverman A.

Gastroenterol Hepatol (N Y). 2012 Jun;8(6):376-83.

15.

Vitamin, mineral, and drug absorption following bariatric surgery.

Sawaya RA, Jaffe J, Friedenberg L, Friedenberg FK.

Curr Drug Metab. 2012 Nov;13(9):1345-55. Review.

16.

The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors.

Hamad GG, Helsel JC, Perel JM, Kozak GM, McShea MC, Hughes C, Confer AL, Sit DK, McCloskey CA, Wisner KL.

Am J Psychiatry. 2012 Mar;169(3):256-63. doi: 10.1176/appi.ajp.2011.11050719.

17.

Effect of gastric bypass surgery on the absorption and bioavailability of metformin.

Padwal RS, Gabr RQ, Sharma AM, Langkaas LA, Birch DW, Karmali S, Brocks DR.

Diabetes Care. 2011 Jun;34(6):1295-300. doi: 10.2337/dc10-2140.

18.

Emerging treatment options for type 2 diabetes.

Piya MK, Tahrani AA, Barnett AH.

Br J Clin Pharmacol. 2010 Nov;70(5):631-44. doi: 10.1111/j.1365-2125.2010.03711.x. Review.

Supplemental Content

Support Center